The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Noninvasive Detection of Extracellular pH in Human Benign and Malignant Liver Tumors Using CEST MRI
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As summarized in Table 1, most transformable nanocarriers are calibrated in well-controlled rodent models or 3D spheroids with relatively uniform stimuli, whereas human tumors display pronounced microregional heterogeneity in extracellular pH, enzyme activity and hypoxia.”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [32]
In the citing paper
“Clinical imaging and microelectrode studies indicate that the bulk extracellular pH of many solid tumors often remains around 6.8–7.1, with only patchy acidic niches falling below 6.7, so pH-triggered shrinkers or charge-reversal systems tuned to sharp transitions at pH 6.5–6.8 may transform efficiently in small, severely hypoxic regions but remain inactive in large portions of the lesion [31, 32]”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [32]
In the citing paper
“Clinical imaging and microelectrode studies indicate that the bulk extracellular pH of many solid tumors often remains around 6.8–7.1, with only patchy acidic niches falling below 6.7, so pH-triggered shrinkers or charge-reversal systems tuned to sharp transitions at pH 6.5–6.8 may transform efficiently in small, severely hypoxic regions but remain inactive in large portions of the lesion [31, 32]”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
Research works printed but not linked: 46
- Griffiths, 1991, Are cancer cells acidic, Br J Cancer, 64, 10.1038/bjc.1991.326 · DOI
- Hashim, 2011, Imaging pH and metastasis, NMR BioMed, 24, 10.1002/nbm.1644 · DOI
- Gatenby, 2004, Why do cancers have high aerobic glycolysis, Nat Rev Cancer, 4, 10.1038/nrc1478 · DOI · Paper page
- Gillies, 2007, Hypoxia and adaptive landscapes in the evolution of carcinogenesis, Cancer Metastasis Rev, 26, 10.1007/s10555-007-9065-z · DOI
- Luciani, 2004, Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs, J Natl Cancer Inst, 96, 10.1093/jnci/djh305 · DOI · Paper page
- De Milito, 2005, Proton pump inhibitors may reduce tumour resistance, Expert Opin Pharmacother, 6, 10.1517/14656566.6.7.1049 · DOI
- De Milito, 2005, Tumor acidity, chemoresistance and proton pump inhibitors, Future Oncol, 1, 10.2217/14796694.1.6.779 · DOI
- Hirpara, 2001, Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells, J Biol Chem, 276, 10.1074/jbc.M004687200 · DOI
- Coss, 2003, Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells, Mol Cancer Ther, 2
- Mahoney, 2003, Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro, Biochem Pharmacol, 66, 10.1016/s0006-2952(03)00467-2 · DOI
- Robey, 2009, Bicarbonate increases tumor pH and inhibits spontaneous metastases, Cancer Res, 69, 10.1158/0008-5472.Can-07-5575 · DOI
- Martin, 2012, Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study, Br J Cancer, 106, 10.1038/bjc.2012.58 · DOI
- Silva, 2009, The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion, Cancer Res, 69, 10.1158/0008-5472.Can-08-2394 · DOI
- Mordon, 1994, In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5,6-carboxyfluorescein): instrumental and experimental studies, Photochem Photobiol, 60, 10.1111/j.1751-1097.1994.tb05104.x · DOI
- Martin, 1994, Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy, Cancer Res, 54
- Gallagher, 2008, Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate, Nature, 453, 10.1038/nature07017 · DOI
- Lutz, 2019, Multiparametric statistical quantification of pH heterogeneity by (1) H MRS and MRSI of extracellular pH markers: Proof of principle, NMR BioMed, 32, e4134, 10.1002/nbm.4134 · DOI
- García-Martín, 2001, Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites, Cancer Res, 61
- Khramtsov, 2000, Biological applications of spin pH probes, Cell Mol Biol (Noisy-le-grand), 46
- Delli Castelli, 2014, In vivo maps of extracellular pH in murine melanoma by CEST-MRI, Magn Reson Med, 71, 10.1002/mrm.24664 · DOI
- Sun, 2014, Quantification of iopamidol multi-site chemical exchange properties for ratiometric chemical exchange saturation transfer (CEST) imaging of pH, Phys Med Biol, 59, 10.1088/0031-9155/59/16/4493 · DOI
- Moon, 2015, A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH, Contrast Media Mol Imaging, 10, 10.1002/cmmi.1647 · DOI
- Chen, 2014, Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI, Magn Reson Med, 72, 10.1002/mrm.25053 · DOI
- Longo, 2014, A general MRI-CEST ratiometric approach for pH imaging: demonstration of in vivo pH mapping with iobitridol, J Am Chem Soc, 136, 10.1021/ja5059313 · DOI
- Chen, 2017, Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI, Oncotarget, 8, 10.18632/oncotarget.17404 · DOI
- Wu, 2015, Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging, NMR BioMed, 28, 10.1002/nbm.3284 · DOI
- Jones, 2017, Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI, Mol Imaging Biol, 19, 10.1007/s11307-016-1029-7 · DOI
- Marrero, 2014, ACG clinical guideline: the diagnosis and management of focal liver lesions, Am J Gastroenterol, 109, 10.1038/ajg.2014.213 · DOI
- Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, 10.1002/ijc.29210 · DOI · Paper page
- Kim, 2009, Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments, Magn Reson Med, 69, 10.1002/mrm.21873 · DOI
- Huang, 2015, Novel gradient echo sequencebased amide proton transfer magnetic resonance imaging in hyperacute cerebral infarction, Mol Med Rep, 11, 10.3892/mmr.2015.3165 · DOI
- Dai, 2014, Magnetization transfer prepared gradient echo MRI for CEST imaging, PLoS One, 9, e112219, 10.1371/journal.pone.0112219 · DOI
- Bryant, 1996, The dynamics of water-protein interactions, Annu Rev Biophys Biomol Struct, 25, 29, 10.1146/annurev.bb.25.060196.000333 · DOI
- Longo, 2016, In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents, Invest Radiol, 51, 10.1097/rli.0000000000000217 · DOI
- Chen, 2015, Evaluations of Tumor Acidosis Within In Vivo Tumor Models Using Parametric Maps Generated with Acido CEST MRI, Mol Imaging Biol, 17, 10.1007/s11307-014-0816-2 · DOI
- Muller-Lutz, 2014, Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner, MAGMA, 27, 10.1007/s10334-014-0433-8 · DOI
- Harston, 2015, Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging, Brain, 138, 36, 10.1093/brain/awu374 · DOI
- Lin, 2018, APT Weighted MRI as an Effective Imaging Protocol to Predict Clinical Outcome After Acute Ischemic Stroke, Front Neurol, 9, 10.3389/fneur.2018.00901 · DOI
- Lindeman, 2018, A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH, Magn Reson Med, 79, 10.1002/mrm.26924 · DOI
- Heo, 2016, Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T, J Magn Reson Imaging, 44, 41, 10.1002/jmri.25108 · DOI
- McVicar, 2014, Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI, J Cereb Blood Flow Metab, 34, 10.1038/jcbfm.2014.12 · DOI
- Jones, 2018, Clinical applications of chemical exchange saturation transfer (CEST) MRI, J Magn Reson Imaging, 47, 11, 10.1002/jmri.25838 · DOI
- Sun, 2008, Imaging pH using the chemical exchange saturation transfer (CEST) MRI: Correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH, Magn Reson Med, 60, 10.1002/mrm.21653 · DOI
- Sun, 2008, Investigation of optimizing and translating pH-sensitive pulsed-chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner, Magn Reson Med, 60, 10.1002/mrm.21714 · DOI
- Shen, 2017, Imaging of nuclear Overhauser enhancement at 7 and 3 T, NMR BioMed, 30, 10.1002/nbm.3735 · DOI
- Jin, 2013, MR imaging of the amide-proton transfer effect and the pH-insensitive nuclear overhauser effect at 9.4 T, Magn Reson Med, 69, 10.1002/mrm.24315 · DOI
Cited by
Sorted by citations
Sheng, J., Yuan, W., Zhang, M., Chen, Z., Qi, Y., Zhao, Y., & Zhang, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04028-7 · Cited by 35
Metadata
- Authors
- Tang, Y., Xiao, G., Shen, Z., Zhuang, C., Xie, Y., Zhang, X., Yang, Z., Guan, J., Shen, Y., Chen, Y., Lai, L., Chen, Y., Chen, S., Dai, Z., Wang, R., & Wu, R.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-02
- Volume
- 10
- ISSN
- 2234-943X
- PMC
- PMC7667286
- Cited by
- 56
- References
- 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noninvasive Detection of Extracellular pH in Human Benign and Malignant Liver Tumors Using CEST MRI. https://app.cochat.ai/papers/10.3389/fonc.2020.578985
- The paper
- Tang, Y., Xiao, G., Shen, Z., Zhuang, C., Xie, Y., Zhang, X., Yang, Z., Guan, J., Shen, Y., Chen, Y., Lai, L., Chen, Y., Chen, S., Dai, Z., Wang, R., & Wu, R. (2020). Noninvasive Detection of Extracellular pH in Human Benign and Malignant Liver Tumors Using CEST MRI. Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.578985